| Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas FC Geyer, B Weigelt, R Natrajan, MBK Lambros, D de Biase, R Vatcheva, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 235 | 2010 |
| Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping R Trisolini, A Cancellieri, C Tinelli, D de Biase, I Valentini, G Casadei, ... Chest 148 (6), 1430-1437, 2015 | 146 | 2015 |
| Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance G Acquaviva, M Visani, A Repaci, KJ Rhoden, D de Biase, A Pession, ... Histopathology 72 (1), 6-31, 2018 | 121 | 2018 |
| TERT Promoter Mutations in Papillary Thyroid Microcarcinomas D de Biase, G Gandolfi, M Ragazzi, M Eszlinger, V Sancisi, M Gugnoni, ... Thyroid 25 (9), 1013-1019, 2015 | 118 | 2015 |
| Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III M Visani, D De Biase, G Marucci, S Cerasoli, E Nigrisoli, MLB Reggiani, ... Molecular oncology 8 (2), 417-430, 2014 | 115 | 2014 |
| Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review S Fiorino, L Bacchi-Reggiani, D De Biase, A Fornelli, M Masetti, A Tura, ... World journal of gastroenterology 21 (45), 12896, 2015 | 107 | 2015 |
| aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia D Grifoni, F Garoia, P Bellosta, F Parisi, D De Biase, G Collina, D Strand, ... Oncogene 26 (40), 5960-5965, 2007 | 102 | 2007 |
| Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy) D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ... PloS one 8 (12), e83607, 2013 | 97 | 2013 |
| What is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization classification of female genital tumors A De Leo, D Santini, C Ceccarelli, G Santandrea, A Palicelli, G Acquaviva, ... Diagnostics 11 (4), 697, 2021 | 95 | 2021 |
| Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications AA Brandes, E Franceschi, A Paccapelo, G Tallini, D De Biase, ... The oncologist 22 (4), 432-437, 2017 | 93 | 2017 |
| High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary … D de Biase, V Cesari, M Visani, GP Casadei, N Cremonini, G Gandolfi, ... The Journal of Clinical Endocrinology & Metabolism 99 (8), E1530-E1538, 2014 | 87 | 2014 |
| Role of microRNAs in the main molecular pathways of hepatocellular carcinoma F Vasuri, M Visani, G Acquaviva, T Brand, M Fiorentino, A Pession, ... World journal of gastroenterology 24 (25), 2647, 2018 | 86 | 2018 |
| MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma S Fiorino, ML Bacchi-Reggiani, M Visani, G Acquaviva, A Fornelli, ... World journal of gastroenterology 22 (15), 3907, 2016 | 85 | 2016 |
| Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment S Moretti, E Menicali, P Voce, S Morelli, S Cantarelli, M Sponziello, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E832-E840, 2014 | 83 | 2014 |
| Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas S Asioli, A Righi, D De Biase, L Morandi, V Caliendo, F Picciotto, ... Modern Pathology 24 (11), 1451-1461, 2011 | 82 | 2011 |
| Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy S Fiorino, C Gallo, M Zippi, S Sabbatani, R Manfredi, R Moretti, E Fogacci, ... Aging clinical and experimental research 32, 2115-2131, 2020 | 80 | 2020 |
| 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed … A Altimari, D de Biase, G De Maglio, E Gruppioni, E Capizzi, ... OncoTargets and therapy, 1057-1064, 2013 | 78 | 2013 |
| Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions D de Biase, M Visani, P Baccarini, AM Polifemo, A Maimone, A Fornelli, ... PloS one 9 (2), e87651, 2014 | 75 | 2014 |
| Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis S Piana, M Ragazzi, G Tallini, D de Biase, A Ciarrocchi, A Frasoldati, ... Human pathology 44 (4), 556-565, 2013 | 71 | 2013 |
| Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation L Morandi, D de Biase, M Visani, V Cesari, G De Maglio, S Pizzolitto, ... PloS one 7 (4), e36084, 2012 | 71 | 2012 |
Michela VisaniUniversità di BolognaVerified email at unibo.it
